Session Tracks

This session will explore the intricate immunometabolic pathways that influence tumor progression and metastasis. Researchers will present novel findings on how metabolic alterations in tumors affect immune cell behavior and tumor microenvironment dynamics.

This track will focus on the role of metabolic regulation in modulating immune cell functions within the tumor microenvironment. Discussions will include how metabolic pathways can be targeted to enhance anti-tumor immunity.

This session will highlight innovative translational research aimed at bridging the gap between basic immunometabolism studies and clinical application in cancer immunotherapy. Presentations will cover recent advancements in therapeutic strategies that manipulate metabolic pathways to improve patient outcomes.

This track will delve into the complex interactions between the tumor microenvironment and immune metabolism. Researchers will discuss how tumor-associated factors influence immune cell metabolism and the implications for cancer therapy.

This session will examine the role of metabolic signaling pathways in cancer cells and their interactions with immune cells. The focus will be on understanding how these signaling networks can be targeted to enhance therapeutic efficacy.

This track will explore the identification and validation of emerging biomarkers related to immunometabolism in cancer. Presentations will discuss their potential utility in predicting treatment responses and patient prognosis.

This session will focus on novel strategies for targeting metabolic pathways as a means to enhance cancer therapy. Researchers will present preclinical and clinical data on the efficacy of metabolic inhibitors in combination with immunotherapeutic agents.

This track will investigate the influence of the gut microbiome on tumor immunometabolism and immune responses. Discussions will include how microbiome modulation can affect cancer therapy outcomes.

This session will address the metabolic adaptations that occur in immune cells within the tumor context. Presentations will highlight how these adaptations can be exploited to improve immunotherapeutic strategies.

This track will focus on integrative approaches that combine genomics, proteomics, and metabolomics to study cancer metabolism. Researchers will share insights on how these multidisciplinary strategies can lead to novel therapeutic targets.

This session will discuss the clinical implications of immunometabolism research in oncology practice. Topics will include the integration of immunometabolic insights into personalized cancer treatment regimens.